Elevated Plasma Glucagon-Like Peptide 1 and 2 Concentrations in Ileum-Resected Short Bowel Patients With a Preserved Colon

Gastroenterology - United Kingdom
doi 10.1016/s0016-5085(00)82333-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Role of Glucagon-Like Peptide–2 Deficiency in Neonatal Short-Bowel Syndrome Using Neonatal Piglets

Pediatric Research
Child HealthPediatricsPerinatology
2013English

Glucagon-Like Peptide-1 and Satiety

Nature
Multidisciplinary
1997English

Orphan Designation: Human Glucagon-Like Peptide-2 Analogue Linked to a Human Immunoglobulin Fc Fragment, Treatment of Short Bowel Syndrome

Case Medical Research
2019English

Pharmacological Characterization of Apraglutide a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist for the Treatment of Short Bowel Syndrome

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2020English

A Biological Function for Glucagon-Like Peptide-2

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1998English

The Relationship Between Sleep and Glucagon-Like Peptide 1 in Patients With Abnormal Glucose Tolerance

Journal of Sleep Research
MedicineBehavioral NeuroscienceCognitive Neuroscience
2017English

Glucagon-Like Peptide-1 (7-37) Augments Insulin Release in Elderly Patients With Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2001English

Effects of Subcutaneous Glucagon-Like Peptide 1 (GLP-1 [7-36 Amide]) in Patients With NIDDM

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1996English

Equine Glucagon-Like Peptide-1 Receptor Physiology

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy